CPHI & PMEC China 2026 is scheduled to be held from June 16 to 18, 2026, at the Shanghai New International Expo Centre. The event, recognized as Asia’s largest pharmaceutical trade show, will build on its previous successes, with expectations of over 110,000 attendees and more than 3,600 exhibitors from local and international markets. This gathering serves as a key platform for sourcing, supply chain optimization, and innovation within China’s pharmaceutical industry, reflecting the country’s growing influence in global pharmaceutical markets. Register now to reserve your place in the event.
Event Highlights and China’s Pharmaceutical Strengths
The 2026 edition will feature expanded zones, including pavilions for Traditional Chinese Medicine and showcases for next-generation active pharmaceutical ingredients, underscoring China’s dual strengths in heritage ingredients and advanced pharmaceutical advancements. New exhibitors and specialized areas for medical aesthetic packaging, frontier technologies, and smart lab spaces will be introduced, enhancing the event’s comprehensive offerings. These additions align with China’s push for innovation and modernization in its pharmaceutical sector, which has seen rapid growth in recent years.
Attendees will have access to Asia’s largest concentration of pharmaceutical machinery manufacturers and cutting-edge production technologies. Live equipment demonstrations, technical seminars, and networking programs, such as the Hosted Buyer Matchmaking Program and plant visits, are designed to facilitate direct connections between international buyers and leading suppliers. These activities support China’s role as a global hub for pharmaceutical building blocks, including APIs, natural extracts, machinery, laboratory instruments, packaging, biotech, and Traditional Chinese Medicine.
Educational and Networking Opportunities
More than 100 conferences and workshops, led by over 700 experts and officials, will provide attendees with market intelligence and technical expertise. These sessions focus on rapid innovation areas, such as investigational drugs, biotech, and machinery developments, positioning participants at the forefront of industry trends. The event’s growth mirrors the pace of innovation in China, solidifying its reputation as a destination for sourcing, supply chain optimization, and strategic partnerships in the pharmaceutical field.
The event’s scale and scope highlight China’s pharmaceutical powerhouse status, offering unparalleled opportunities for global engagement. With its focus on both traditional and modern pharmaceutical elements, CPHI & PMEC China 2026 aims to support the resilience and forward-looking vision of the industry, contributing to China’s economic and trade dynamics in the global market.
